Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Front Psychol ; 12: 676153, 2021.
Article in English | MEDLINE | ID: mdl-34211424

ABSTRACT

Strengths use is an essential personal resource to consider when designing higher-educational programs and interventions. Strengths use is associated with positive outcomes for both the student (e.g., study engagement) and the university (e.g., academic throughput/performance). The Strengths Use Scale (SUS) has become a popular psychometric instrument to measure strengths use in educational settings, yet its use has been subjected to limited psychometric scrutiny outside of the U.S. Further, its longitudinal stability has not yet been established. Given the wide use of this instrument, the goals of this study were to investigate (a) longitudinal factorial validity and the internal consistency of the scale, (b) its equivalence over time, and (c) criterion validity through its relationship with study engagement over time. Data were gathered at two-time points, 3 months apart, from a sample of students in the Netherlands (n = 360). Longitudinal confirmatory factor analyses showed support for a two-factor model for overall strengths use, comprised of Affinity for Strengths and Strengths Use Behaviors. The SUS demonstrated high levels of internal consistency at both the lower- and upper bound limits at both time points. Further, strict longitudinal measurement invariance was established, which confirmed the instrument's temporal stability. Finally, criterion validity was established through relating strengths use to study engagement at different time stamps. These findings support the use of the SUS in practice to measure strengths use and to track the effectiveness of strengths use interventions within the higher education sector.

2.
Pediatr Pulmonol ; 55(9): 2315-2322, 2020 09.
Article in English | MEDLINE | ID: mdl-32441886

ABSTRACT

BACKGROUND: Scond is a multiple breath washout (MBW) index that measures convection-dependent ventilation inhomogeneity (CDI) arising within conductive airways, but the calculation method is unreliable in subjects with advanced cystic fibrosis (CF) lung disease. A new CDI index, Scond *, has been proposed for use in adults with CF and moderate to severe ventilation inhomogeneity. We aimed to evaluate the most appropriate CDI index in children and adolescents with CF and various degrees of inhomogeneity, and from that the most appropriate diffusion-convection-interaction index (Sacin or Sacin *). METHODS: Scond , Sacin  and the alternative indices, Scond *, and Sacin * were retrospectively calculated in subjects with CF aged 3 to 18 years and age-matched controls, who underwent sulfur hexafluoride MBW between 2003 and 2015. The upper limit of normal was based on 95th percentile of the control population. RESULTS: One hundred and twenty-seven subjects with CF (44% male; mean age ± SD: 7.5 years ± 4.9) and 94 controls (53% male; 7.9 years ± 5.1) were included in the final analysis. All measures of ventilation inhomogeneity were significantly higher in children with CF. As predicted, Scond reached a maximum value at lung clearance index (LCI) values of approximately 9. In subjects with LCI ≥ 9 Scond * showed good correlation with LCI, whilst Scond had no relationship with LCI (Spearman rank correlation Scond */LCI, 0.49; P < .01; Scond /LCI, -0.068; P = .46). In subjects with mild disease (LCI < 9) Scond was more frequently abnormal than Scond * (37% vs 16%; P = .01). CONCLUSIONS: Scond and Sacin are sensitive indices of early regional inhomogeneity, but are of no value when LCI ≥ 9. In these subjects, Scond * & Sacin * are potential alternatives.


Subject(s)
Cystic Fibrosis/physiopathology , Lung/physiopathology , Respiratory Function Tests/methods , Adolescent , Child , Child, Preschool , Female , Humans , Male , Respiration , Retrospective Studies , Sulfur Hexafluoride
3.
Int J Radiat Oncol Biol Phys ; 104(2): 279-290, 2019 06 01.
Article in English | MEDLINE | ID: mdl-30703512

ABSTRACT

PURPOSE: Stereotactic body radiation therapy offers good lung local tumor control by the administration of a high dose per fraction in small volumes. Stereotactic body radiation therapy preclinical modeling is now possible, and our aim was to develop a model of focal irradiation of the mouse lung and to investigate the impact of conditional hypoxia-inducible factor 1α (HIF-1α) deletion in the endothelium on radiation-induced tissue damage. METHODS AND MATERIALS: The Small Animal Radiation Research Platform was used to create a mouse model of focal irradiation of the lung using arc therapy. HIF-1α conditional deletion was obtained by crossing mice expressing Cre recombinase under the endothelial promoter VE-cadherin (VECad-Cre+/+ mice) with HIF-1α floxed mice. RESULTS: Lung stereotactic arc therapy allows thoracic wall sparing and long-term studies. However, isodose curves showed that neighboring organs received significant doses of radiation, as revealed by ipsilateral lung acute red hepatization and major gene expression level modifications. Conditional HIF-1α deletion reduced acute lung edema and tended to diminish neutrophil infiltrate, but it had no impact on long-term global tissue damage. CONCLUSIONS: Arc therapy for focal high-dose irradiation of mouse lung is an efficient model for long-term studies. However, irradiation may have a strong impact on the structure and function of neighboring organs, which must be considered. HIF-1α conditional deletion has no beneficial impact on lung damage in this irradiation schedule.


Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit , Lung Neoplasms/radiotherapy , Lung/radiation effects , Organs at Risk/radiation effects , Radiosurgery/methods , Radiotherapy, Intensity-Modulated/methods , Animals , Cone-Beam Computed Tomography , Disease Models, Animal , Epithelial-Mesenchymal Transition , Gene Deletion , Hybridization, Genetic , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Integrases/metabolism , Lung/diagnostic imaging , Mice , Organs at Risk/diagnostic imaging , Phenotype , Pulmonary Alveoli/pathology , Pulmonary Alveoli/radiation effects , Pulmonary Edema/prevention & control , Pulmonary Fibrosis/diagnostic imaging , Radiation Dosage , Radiation Pneumonitis/diagnostic imaging , Radiosurgery/adverse effects , Radiotherapy, Intensity-Modulated/adverse effects , Running/physiology , Selective Breeding
4.
Stem Cell Reports ; 9(6): 2018-2033, 2017 12 12.
Article in English | MEDLINE | ID: mdl-29198825

ABSTRACT

In skeletal muscle, new functions for vessels have recently emerged beyond oxygen and nutrient supply, through the interactions that vascular cells establish with muscle stem cells. Here, we demonstrate in human and mouse that endothelial cells (ECs) and myogenic progenitor cells (MPCs) interacted together to couple myogenesis and angiogenesis in vitro and in vivo during skeletal muscle regeneration. Kinetics of gene expression of ECs and MPCs sorted at different time points of regeneration identified three effectors secreted by both ECs and MPCs. Apelin, Oncostatin M, and Periostin were shown to control myogenesis/angiogenesis coupling in vitro and to be required for myogenesis and vessel formation during muscle regeneration in vivo. Furthermore, restorative macrophages, which have been previously shown to support myogenesis in vivo, were shown in a 3D triculture model to stimulate myogenesis/angiogenesis coupling, notably through Oncostatin M production. Our data demonstrate that restorative macrophages orchestrate muscle regeneration by controlling myogenesis/angiogenesis coupling.


Subject(s)
Cell Differentiation/genetics , Muscle Development/genetics , Muscle, Skeletal/growth & development , Neovascularization, Physiologic/genetics , Regeneration/genetics , Animals , Apelin/genetics , Blood Vessels/growth & development , Blood Vessels/metabolism , Cell Adhesion Molecules/genetics , Cell Movement/genetics , Endothelial Progenitor Cells/metabolism , Gene Expression Regulation, Developmental/genetics , Humans , Macrophages/metabolism , Mice , Myoblasts/cytology , Myoblasts/metabolism , Oncostatin M/genetics , Stem Cells/cytology , Stem Cells/metabolism , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL
...